ResearcherFirst Affiliated Hospital of Bengbu Medical CollegeNo recent work listed

Zhenyuan Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-4727-2529; OpenAlex author ID A5101135272. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis. Co-author DOI 10.1515/med-2020-0157 ↗
SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer. Co-author PMID 26191169 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yimei Ou · 2 shared papers, 2015–2020 · strength 0.20
- Paper SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis. DOI 10.1515/med-2020-0157 ↗
- Paper SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer. PMID 26191169 ↗
Xiao Wu · 1 shared paper, 2020 · strength 0.15
- Paper SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis. DOI 10.1515/med-2020-0157 ↗
Jingjing Zhang · 1 shared paper, 2015 · strength 0.06
- Paper SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer. PMID 26191169 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.